Immunology/Inflammation
Immunology/Inflammation(免疫及炎症)
The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.
Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].
BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].
Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.
Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].
References
[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.
[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.
[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.
[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.
[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.
[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.
[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.
[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.
- 5-Lipoxygenase(11)
- Papain(1)
- PGDS(1)
- PGE synthase(24)
- SIKs(12)
- IκB/IKK(67)
- AP-1(6)
- KEAP1-Nrf2(65)
- NOD1(1)
- TLR(140)
- NF-κB(241)
- Interleukin Related(171)
- 15-lipoxygenase(2)
- Others(63)
- Aryl Hydrocarbon Receptor(36)
- CD73(14)
- Complement System(58)
- Galectin(12)
- IFNAR(25)
- NO Synthase(77)
- NOD-like Receptor (NLR)(51)
- STING(110)
- Reactive Oxygen Species(465)
- Apoptosis(802)
- FKBP(20)
- eNOS(5)
- iNOS(29)
- nNOS(20)
- Glutathione(57)
- Adaptive Immunity(222)
- Allergy(130)
- Arthritis(34)
- Autoimmunity(190)
- Gastric Disease(101)
- Immunosuppressants(39)
- Immunotherapeutics(5)
- Innate Immunity(593)
- Pulmonary Diseases(119)
- Reactive Nitrogen Species(55)
- Reactive Sulfur Species(28)
- Specialized Pro-Resolving Mediators(50)
- Cyclic GMP-AMP Synthase(2)
- BCL6(3)
- CD20(3)
- CD22
- CD28(1)
- FAP(7)
- PSMA(7)
- Nuclear Factor of activated T Cells (NFAT)(1)
- Glycoprotein VI(1)
- Tim3(2)
- Hapten(1)
- Nectin-4(2)
Immunology/Inflammation 相关产品(4245)
- GC72792CyclopentenylcytosineCAS: 90597-22-1纯度: >99.00%
Cyclopentenylcytosine(CPC)是一种核苷类似物,通过抑制CTP合成酶来降低白血病细胞中胞苷三磷酸(CTP)和脱氧胞苷三磷酸盐(dCTP)的水平。
- GC72878UCD38B hydrochlorideCAS: 1115177-19-9纯度: >99.00%
UCD38B hydrochloride是一种细胞渗透的竞争性酶促uPA抑制剂,IC50值为7 μM。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC72791 | Delmitide acetate | 501019-16-5 | >98.00% | |
Delmitide acetate是一种口服活性d-异构体十肽,具有强效抗炎活性。 | ||||
| GC72792 | Cyclopentenylcytosine | 90597-22-1 | >99.00% | |
Cyclopentenylcytosine(CPC)是一种核苷类似物,通过抑制CTP合成酶来降低白血病细胞中胞苷三磷酸(CTP)和脱氧胞苷三磷酸盐(dCTP)的水平。 | ||||
| GC72803 | Aspidin BB | 584-28-1 | >98.00% | |
Aspidin BB是一种间苯三酚衍生物,可从冠毛鳞毛蕨的地上部分分离得到。 | ||||
| GC72817 | BAI1 hydrochloride | 329349-20-4 | >99.00% | |
BAI1 hydrochloride是一种选择性凋亡因子BAX变构抑制剂。 | ||||
| GC72824 | KX2-361 | 897016-26-1 | >99.00% | |
KX2-361(KX-02)是一种Src激酶和微管蛋白聚合抑制剂。 | ||||
| GC72826 | CB7993113 | 819827-50-4 | >98.00% | |
CB7993113是一种强效的AHR拮抗剂,IC50为0.33μM。 | ||||
| GC72835 | NSC260594 | 906718-66-9 | >96.00% | |
NSC260594诱导细胞凋亡。 | ||||
| GC72851 | Belapectin | 1980787-47-0 | >99.00% | |
Belapectin (GR-MD-02)是半乳糖凝集素-3 (Gal-3)抑制剂。 | ||||
| GC72852 | Helenalin acetate | 10180-86-6 | >98.00% | |
Helenalin acetate是一种天然的NF-κB抑制剂,是一种有效的C/EBPβ抑制剂。 | ||||
| GC72858 | Avenanthramide A | 108605-70-5 | >99.00% | |
Avenanthramide A是一种可以在燕麦(Avena sativa L)。 | ||||
| GC72862 | Erasin | - | >96.00% | |
Erasin是一种强效的厄洛替尼抗性拮抗STAT3抑制剂,对STAT3和STAT1的IC50分别为9.7和24μM。 | ||||
| GC72864 | PZ703b hydrochloride | - | >99.00% | |
PZ703b hydrochloride是一种Bcl-xl PROTAC降解剂,可诱导细胞凋亡,抑制癌细胞增殖。 | ||||
| GC72868 | AZA197 | 1249398-09-1 | >98.00% | |
AZA197是Cdc42的选择性小分子抑制剂。 | ||||
| GC72875 | Justicidin A | 25001-57-4 | >99.00% | |
Justicidin A是一种天然产物,可以从Justicia procumbens中分离出来。 | ||||
| GC72878 | UCD38B hydrochloride | 1115177-19-9 | >99.00% | |
UCD38B hydrochloride是一种细胞渗透的竞争性酶促uPA抑制剂,IC50值为7 μM。 | ||||
| GC72888 | CPS-11 | 145945-21-7 | >99.00% | |
CPS-11(N-(droxymetl)沙利度胺)是沙利度胺类似物,是一种强效抗癌剂。 | ||||
| GC72892 | Oblimersen sodium | - | >98.00% | |
Oblimersen sodium是一种针对BCL-2 RNA的BCL-2抑制剂。 | ||||
| GC72910 | DD1 | 187585-11-1 | >99.00% | |
DD1蛋白酶体抑制剂,靶向急性髓系白血病(AML)凋亡过程中Bax的激活和P70S6K的降解。 | ||||
| GC72915 | (R)-MRT199665 | - | >98.00% | |
(R)-MRT199665是MRT199665的异构体。 | ||||
| GC72924 | PD173952 | 305820-75-1 | >99.00% | |
PD173952是一种酪氨酸激酶抑制剂,对Lyn、Abl和Csk的ic50分别为0.3、1.7和6.6 nM。 | ||||
| GC72928 | DB818 | 790241-43-9 | >98.00% | |
DB818是homobox A9 (HOXA9)的有效抑制剂。 | ||||
| GC72929 | DB818 dihydrochloride | - | 不显示 | |
DB818 dihydrochloride是DB818的二氯盐形式。 | ||||
| GC72933 | LQZ-7F | 354543-09-2 | >97.00% | |
LQZ-7F是一种survivin二聚化抑制剂,在前列腺癌细胞中诱导自发凋亡并与多西他赛协同作用。 | ||||
| GC72944 | MMRi64 | 430458-66-5 | >98.00% | |
MMRi64破坏Mdm2-MdmX相互作用。 | ||||
